Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 3—March 2015

Risk Factors for Death from Invasive Pneumococcal Disease, Europe, 2010

Adoración Navarro-TornéComments to Author , Joana Gomes Dias, Frantiska Hruba, Pier Luigi Lopalco, Lucia Pastore-Celentano, Andrew J. Amato Gauci, and Invasive Pneumococcal Disease Study Group
Author affiliations: Universidad Autónoma de Barcelona, Barcelona, Spain (A. Navarro-Torné); European Centre for Disease Prevention and Control, Stockholm, Sweden (A. Navarro-Torné, J. Gomes Dias, F. Hruba, P.L. Lopalco, L. Pastore-Celentano, A.J. Amato Gauci)

Main Article

Table 4

Association between invasive pneumococcal disease study variables and death, Europe, 2010*

Variable Relative risk† (95% CI)
F Reference
M 1.06 (0.88–1.28)
Age group, y
<5 Reference
5–64 3.55 (1.66–7.61)
>65 4.79 (3.08–11.76)
Clinical presentation
Nonmeningitis Reference
Meningitis 1.81 (1.25–2.61)
PCV13-specific‡ Reference
PCV7 2.18 (1.06–4.48)
Non-PCV 1.47 (0.94–2.28)
Antimicrobial susceptibility
Susceptible Reference
Nonsusceptible§ 1.91 (1.16–3.13)
Susceptible Reference
Nonsusceptible 1.04 (0.84–1.29)

*PCV, pneumococcal conjugate vaccine; PCV7, 7-valent PCV; PCV13, 13-valent PCV..
†Generalized linear model with log-link function.
‡Serotypes contained in PCV13 but not in PCV7.
§Either resistant or intermediate resistance.

Main Article

1Members of the Invasive Pneumococcal Disease Study Group who contributed data are listed at the end of this article.

Page created: April 16, 2015
Page updated: April 16, 2015
Page reviewed: April 16, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.